Sign in

CIK 0000320017

  • Non-accelerated filer
  • Smaller reporting company

LISATA THERAPEUTICS, INC.

Sign in to watch
Ticker
LSTA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
222343568
Phone
+1 908-229-2590
Business address
110 ALLEN ROAD, SECOND FLOOR, BASKING RIDGE, NJ, 07920
Former names
Caladrius Biosciences, Inc., CALADRIUS BIOSCIENCES, INC., NeoStem, Inc., PHASE III MEDICAL INC/DE, CORNICHE GROUP INC /DE
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-01-09 Buck Kristen K EVP, R&D and CMO Shares withheld for taxes −1,908 $3.80 $7K 80,250
2025-01-09 Buck Kristen K EVP, R&D and CMO Grant or award · Stock Option (Right to Buy) +13,000 13,000
2025-01-09 Flowers Cynthia Louise Director Grant or award +15,789 64,990
2025-01-09 BROWN GREGORY B Director Grant or award +15,789 65,203
2025-01-09 Mazzo David J President & CEO Grant or award +81,000 295,152
2025-01-09 Mazzo David J President & CEO Shares withheld for taxes −9,414 $3.80 $36K 285,738
2025-01-09 Mazzo David J President & CEO Shares withheld for taxes −10,925 $3.80 $42K 274,813
2025-01-09 Mazzo David J President & CEO Shares withheld for taxes −7,017 $3.80 $27K 267,796
2025-01-09 Mazzo David J President & CEO Grant or award · Stock Option (Right to Buy) +40,000 40,000
2025-01-09 AZAB MOHAMMAD Director Grant or award +15,789 74,469
2025-01-09 HENSON HEIDI Director Grant or award +15,789 55,269
2025-01-09 KLOSK STEVEN M Director Grant or award +15,789 65,359
2024-10-01 Nisco James SVP, Fin/Treas, Chief Actg Off Grant or award +3,300 $2.93 $10K 14,657
2024-10-01 Nisco James SVP, Fin/Treas, Chief Actg Off Shares withheld for taxes −1,701 $2.93 $5K 12,956
2024-10-01 Buck Kristen K EVP, R&D and CMO Grant or award +15,000 $2.93 $44K 69,035
2024-10-01 Buck Kristen K EVP, R&D and CMO Shares withheld for taxes −6,363 $2.93 $19K 62,672
2024-10-01 Mazzo David J President & CEO Grant or award +58,000 $2.93 $170K 238,798
2024-10-01 Mazzo David J President & CEO Shares withheld for taxes −26,964 $2.93 $79K 211,834
2024-01-11 Mazzo David J Chief Executive Officer Shares withheld for taxes −1,026 $2.99 $3K 174,766
2024-01-10 Buck Kristen K EVP, R&D and CMO Shares withheld for taxes −512 $3.00 $2K 54,035

Page 3 of 18 · 345 trades